SNOMED International’s Global Patient Set: Navigating International Patient Care and Interoperability

LONDON, April 17, 2019 (GLOBE NEWSWIRE) — At SNOMED International’s April Business Meeting held in London last week, the organization announced to its Community of Practice the planned release of a Global Patient Set built from its globally recognized SNOMED CT clinical terminology standard. SNOMED International will release the Global Patient Set, or GPS, to […]

Read more

SNOMED International’s Global Patient Set: Navigating International Patient Care and Interoperability

LONDON, April 17, 2019 (GLOBE NEWSWIRE) — At SNOMED International’s April Business Meeting held in London last week, the organization announced to its Community of Practice the planned release of a Global Patient Set built from its globally recognized SNOMED CT clinical terminology standard. SNOMED International will release the Global Patient Set, or GPS, to […]

Read more

QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.

Press Release: 17 April 2019 QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group. Quality control testing for autologous C&GT’s can be challenging as they are manufactured in small […]

Read more